Form 8-K - Current report:
SEC Accession No. 0001829126-23-003881
Filing Date
2023-06-02
Accepted
2023-06-02 16:41:40
Documents
15
Period of Report
2023-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexalin_8k.htm   iXBRL 8-K 45684
2 EXHIBIT 99.1 nexalin_ex99-1.htm EX-99.1 11008
3 GRAPHIC ex99-1_001.jpg GRAPHIC 25962
  Complete submission text file 0001829126-23-003881.txt   316374

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nxl-20230531.xsd EX-101.SCH 3712
5 XBRL DEFINITION FILE nxl-20230531_def.xml EX-101.DEF 26631
6 XBRL LABEL FILE nxl-20230531_lab.xml EX-101.LAB 36725
7 XBRL PRESENTATION FILE nxl-20230531_pre.xml EX-101.PRE 25255
9 EXTRACTED XBRL INSTANCE DOCUMENT nexalin_8k_htm.xml XML 5608
Mailing Address 26072 MERIT CIRCLE, SUITE 106 LAGUNA NIGUEL CA 92653
Business Address 26072 MERIT CIRCLE, SUITE 106 LAGUNA NIGUEL CA 92653 949-260-8090
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 23989582
SIC: 3845 Electromedical & Electrotherapeutic Apparatus